KRM Ayurveda share price
NSE: KRMAYURVEDPharmaceuticals & Biotechnology
KRM Ayurveda Limited · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Jan 2026 · Issue price ₹135
Last close ₹230.15down ₹0.75 (0.32%)
Share price at the NSE close on 27 Oct 2026. Previous close ₹230.90.
27 Oct: open ₹231.00, high ₹235.00, low ₹229.50
Range of traded prices from listing on 29 Jan 2026 to 27 Oct 2026
₹156.15Low, 4 Feb 2026₹343.95High, 10 Aug 2026
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. Market capitalisation: how it is worked out
- ₹489 Cr
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- No full year
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 4.27
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonesince listing in Jan 2026
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.00
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 40,00070.0% delivered
Results
Standalone; ₹ crore.KRM Ayurveda quarterly results
Year to Mar 2026
- Revenue
- ₹102 Cr
- Net profit
- ₹20 Cr
- Net marginNet margin. Net profit as a percentage of revenue: how much of each rupee of sales is left after every cost, interest and tax. Net margin in the glossary
- 19.8%
| ₹ crore | Mar 2026 |
|---|---|
| Revenue | 102 |
| Net profit | 20 |
| Net margin | 19.8% |
Standalone. Years to March.
Quarter to Jun 2026
- Revenue
- ₹32 Cr
- Net profit
- ₹9.08 Cr
- Net margin
- 28.1%
| ₹ crore | Jun 2026 |
|---|---|
| Revenue | 32.3 |
| Net profit | 9.1 |
| Net margin | 28.1% |
Standalone. The quarter to Jun 2026, the first on record.
Business segments
In the quarter to Jun 2026 the company reports one business segment which carries all its revenue.
Promoter and insider buying and selling
Trades made since 28 Oct 2025.KRM Ayurveda insider trading
Bought on the marketBought on the market. The value each filer stated for its purchases on the exchange, added up; gifts, transfers and pledges are not counted. A purchase filed with no value is counted under the sum, not in it. Sold on the marketSold on the market. The value each filer stated for its sales on the exchange, added up; gifts, transfers and pledges are not counted. A sale filed with no value is counted under the sum, not in it.
- Promoters and promoter group5 purchases, 0 sales₹2.51 CrNo saleNetNet. The value bought on the market less the value sold, over the trades whose filers stated a value.₹2.51 Cr
- Directors and key managers10 purchases, 0 sales₹5.38 CrNo saleNet₹5.38 Cr
Bought and sold count trades on the market only. A pledge is shares given to a lender as security for a loan; a lender invokes it by selling them.
KRM Ayurveda competitors and peers
Pharmaceuticals, 216 listed companies, priced on 27 Oct 2026. The table lists the 8 companies closest to KRM Ayurveda in market cap.Healthcare companies
KRM Ayurveda is not on the chart: it has no P/E or return on equity today
| Company | ||||||||
|---|---|---|---|---|---|---|---|---|
 Amanta HealthcareAMANTA | 612 | 41.73 | 2.78 | – | – | 6.7% | 9.0% | 0.00% |
 Influx HealthtechINFLUX | 588 | 28.59 | 5.83 | – | – | 20.4% | – | 0.00% |
 Trident LifelineTLL | 521 | 24.78 | 4.57 | – | – | 22.3% | – | 0.00% |
 TranschemTRANSCHEM | 499 | 74.25 | 5.97 | −100.0% | +47.5% | 8.3% | −4.9% | 0.00% |
 Infinium PharmachemINFINIUM | 446 | 36.68 | 3.68 | +21.8% | +41.8% | 10.5% | – | 0.00% |
 Haleos LabsHALEOSLABS | 446 | 28.20 | 2.09 | −3.1% | −8.5% | 7.7% | 7.4% | 0.10% |
 Albert DavidALBERTDAVD | 443 | 19.62 | 1.13 | +11.4% | +258.5% | 5.8% | 4.1% | 0.64% |
 Jenburkt PharmaceuticalsJENBURPH | 386 | 11.77 | 1.96 | +9.1% | +1.2% | 17.8% | 19.2% | 2.36% |
Market cap in ₹ crore. Growth is the last twelve months against the twelve before. A figure is left empty where it would rest on a loss or the company has under a year of results on record. ROE is the shareholders' profit over their net worth. ROCE is profit before interest and tax over the whole group's net worth plus borrowings, as in the figures at the top of the page.
Latest announcements
Routine notices left out.KRM Ayurveda announcements
Oct 2026
Sep 2026
30 Sep · Meeting
Recent sessions
The 9 trading days to 26 Oct 2026, as traded on NSE; the latest is at the top of the page.
| Date | Open | High | Low | Close | Average price | Volume | Delivery |
|---|---|---|---|---|---|---|---|
| 26 Oct 2026 | 232.00 | 235.00 | 227.80 | 230.90 | 230.51 | 71,000 | 52.1% |
| 23 Oct 2026 | 232.20 | 243.50 | 224.00 | 238.80 | 232.92 | 61,000 | 60.7% |
| 22 Oct 2026 | 235.00 | 235.00 | 230.00 | 233.05 | 233.01 | 20,000 | 85.0% |
| 21 Oct 2026 | 244.00 | 245.00 | 221.35 | 237.90 | 236.87 | 2,03,000 | 72.4% |
| 19 Oct 2026 | 262.00 | 262.00 | 244.00 | 246.60 | 249.60 | 1,17,000 | 69.2% |
| 16 Oct 2026 | 263.25 | 264.15 | 261.00 | 261.45 | 262.75 | 16,000 | 87.5% |
| 15 Oct 2026 | 270.80 | 274.95 | 264.15 | 265.50 | 267.80 | 35,000 | 82.9% |
| 14 Oct 2026 | 271.00 | 274.00 | 266.05 | 269.50 | 268.64 | 28,000 | 67.9% |
| 13 Oct 2026 | 266.00 | 272.95 | 263.00 | 270.20 | 267.56 | 1,64,000 | 87.8% |
Prices in ₹ per share as traded, not adjusted.
Company details
- NSE symbol
- KRMAYURVED
- ISIN
- INE1MTV01019
- Industry
- Pharmaceuticals & Biotechnology